Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Innoviva, Inc. Director's Dealing 2012

Feb 17, 2012

32090_dirs_2012-02-17_5f02750d-2740-43bb-8b8c-7f62a465a04a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: THERAVANCE INC (THRX)
CIK: 0001080014
Period of Report: 2012-02-15

Reporting Person: Shafer Bradford J (Sr VP, Gen. Counsel, Secretary)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-02-15 Common Stock A 5000 Acquired 355673 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 2750 Indirect
Common Stock 2750 Indirect
Common Stock 2750 Indirect

Footnotes

F1: Shares held in trust for the benefit of a child of the reporting person. Reporting person is a trustee of the trust. Reporting person disclaims beneficial ownership of these shares.